Overview
Greg Palmer obtained his B.S. in Biomedical Engineering from Marquette University in 2000, after which he obtained his Ph.D. in BME from the University of Wisconsin, Madison. He is currently an Associate Professor in the Department of Radiation Oncology, Cancer Biology Division at Duke University Medical Center. His primary research focus has been identifying and exploiting the changes in absorption, scattering, and fluorescence properties of tissue associated with cancer progression and therapeutic response. To this end he has implemented a model-based approach for extracting absorber and scatterer properties from diffuse reflectance and fluorescence measurements. More recently he has developed quantitative imaging methodologies for intravital microscopy to characterize tumor functional and molecular response to radiation and chemotherapy. His awards have included the Jack Fowler Award from the Radiation Research Society.
Laboratory Website:
https://radonc.duke.edu/research-education/research-labs/radiation-and-cancer-biology/palmer-lab
Laboratory Website:
https://radonc.duke.edu/research-education/research-labs/radiation-and-cancer-biology/palmer-lab
Current Duke Appointments & Affiliations
Professor of Radiation Oncology
·
2023 - Present
Radiation Oncology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2012 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
Multiscale modeling uncovers macrophage infiltration and TNF-α signaling networks for targeting in inflammatory breast cancer tumor emboli.
Journal article Breast · October 2026 PURPOSE: Inflammatory breast cancers (IBC) are characterized by diffuse clusters of cells found in dermal lymphatic vessels, known as tumor emboli. IBC needs a novel treatment because it is the most aggressive breast cancer form. We hypothesized that the i ... Full text Link to item CiteIn vivo imaging of metabolic heterogeneity across three endpoints relevant to aggressive breast cancer.
Journal article PNAS Nexus · March 2026 Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with poor prognosis and a high likelihood of recurrence. Residual disease after therapy is a key predictor of recurrence, often driven by intratumoral metabolic heterogeneity. A ... Full text Link to item CiteTumor emboli in inflammatory breast cancer reveals macrophage-TNF-a signaling networks as targetable pathways
Conference CLINICAL CANCER RESEARCH · February 17, 2026 Link to item CiteRecent Grants
Development of CapCell Scope for Metabolic Imaging of Tissue Heterogeneity and Therapy Response
ResearchCo Investigator · Awarded by National Institute of Biomedical Imaging and Bioengineering · 2019 - 2028Red blood cell ATP export and transfusion in sepsis (R01)
ResearchCo Investigator · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2026Preventing Inflammatory Breast Cancer Metastases by Interrupting Cellular Stress Signaling in Lymphatic Emboli and Circulating Tumor Cell Clusters
ResearchCo Investigator · Awarded by Department of Defense · 2020 - 2025View All Grants
Education
University of Wisconsin, Madison ·
2005
Ph.D.